Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice<\/title><secondary-title>Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen<\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1159\/000336871<\/electronic-resource-num><urls><related-urls><url>https:\/\/core.ac.uk\/download\/16432283.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chiara Russo<\/author><author>Franziska Ferk<\/author><author>Miroslav Mi\u0161\u00edk et al.<\/author><\/authors><\/contributors><titles><title>Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells<\/title><secondary-title>Archives of Toxicology<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1007\/s00204-018-2322-9<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-018-2322-9.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gemma Navarro<\/author><author>Katia Varani<\/author><author>Alejandro Lillo et al.<\/author><\/authors><\/contributors><titles><title>Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1\/CB2 heteromer receptors<\/title><secondary-title>Pharmacological Research<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1016\/j.phrs.2020.104940<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043661820312482<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samuel B\u00fcechi<\/author><\/authors><\/contributors><titles><title>Wirksamkeit von Cannabidiol: Klinische Studien mit Cannabidiol und Cannabidiol-haltigen Extrakten<\/title><secondary-title>Schweizerische Zeitschrift f\u00fcr Ganzheitsmedizin \/ Swiss Journal of Integrative Medicine<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1159\/000484886<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1159\/000484886<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mark Feldman<\/author><author>Ronit Vogt Sionov<\/author><author>Raphael Mechoulam et al.<\/author><\/authors><\/contributors><titles><title>Anti-Biofilm Activity of Cannabidiol against Candida albicans<\/title><secondary-title>Microorganisms<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.3390\/microorganisms9020441<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2076-2607\/9\/2\/441\/pdf?version=1613815842<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jian Huang<\/author><author>Xiao Fan<\/author><author>Xueqin Jin et al.<\/author><\/authors><\/contributors><titles><title>Cannabidiol inhibits Nav channels through two distinct binding sites<\/title><secondary-title>Nature Communications<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1038\/s41467-023-39307-6<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41467-023-39307-6.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chiara Russo<\/author><author>Margherita Lavorgna<\/author><author>Roberta Nugnes et al.<\/author><\/authors><\/contributors><titles><title>Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin<\/title><secondary-title>Scientific Reports<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1038\/s41598-021-01975-z<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41598-021-01975-z.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sasithorn Limsuwan<\/author><author>Natthaporn Phonsatta<\/author><author>Atikorn Panya et al.<\/author><\/authors><\/contributors><titles><title>Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs<\/title><secondary-title>Frontiers in Veterinary Science<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.3389\/fvets.2024.1389810<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1389810\/pdf?isPublishedV2=False<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Amorphous Solid Dispersion Hydrogel Platform for Transdermal Delivery of Cannabidiol with Therapeutic Potential for Dermatitis.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/pharmaceutics18060666<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13306709?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Encapsulation of Cannabidiol in Chitosan-Stabilized Argan Oil Nanoemulsion as a Potential Dermal Drug Delivery System for Psoriasis Treatment.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/pharmaceutics18030286<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13029121?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agents.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1186\/s42238-026-00403-1<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC12964675?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Moreira FA<\/author><author>de Oliveira ACP<\/author><author>Santos VR et al.<\/author><\/authors><\/contributors><titles><title>Cannabidiol and epilepsy.<\/title><secondary-title>International review of neurobiology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1016\/bs.irn.2024.03.009<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jimbo Sotomayor<\/author><author>Ruth Elizabeth<\/author><\/authors><\/contributors><titles><title>Cannabidiol: uso en epilepsias refractarias<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.33588\/rn.6504.2016573<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Rose Chesworth<\/author><author>David Cheng<\/author><author>Chloe Staub et al.<\/author><\/authors><\/contributors><titles><title>Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer\u2019s disease mouse model<\/title><secondary-title>Frontiers in Pharmacology<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.3389\/fphar.2022.931384<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.3389\/fphar.2022.931384<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Carley Marie Huffstetler<\/author><author>Brigitte Cochran<\/author><author>Camilla Ann May et al.<\/author><\/authors><\/contributors><titles><title>Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner<\/title><secondary-title>Pharmacology Biochemistry and Behavior<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1016\/j.pbb.2022.173498<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0091305722001770\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Eva Tav\u010dar Benkovi\u0107<\/author><author>Marko Vidak<\/author><\/authors><\/contributors><titles><title>Experimental investigation and thermodynamic modelling of cannabidiol and curcumin in different solvents<\/title><secondary-title>Journal of Molecular Liquids<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1016\/j.molliq.2024.125511<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1016\/j.molliq.2024.125511<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015\/2283.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.2903\/j.efsa.2026.10154<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13586991?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>In Silico<\/i> Exploration of Cannabidiol Interactions with Outer Membrane Proteins in Salmonella<\/i> Typhimurium LT2.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/ijms27188247<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13607420?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Safety of cannabidiol isolated from Cannabis sativa<\/i> L. as a novel food pursuant to Regulation (EU) 2015\/2283.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.2903\/j.efsa.2026.10318<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13591334?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Design, Synthesis, In Silico and In Vitro Pharmacological Profiling of Cannabidiol-like Synthetic Analogues as Multi-Target Anti-Alzheimer's Agents.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/molecules31152657<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13468590?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>Martin Storr<\/author>Storr<\/author>Martin<\/author>Rudolf Schicho et al.<\/author><\/authors><\/contributors>Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice<\/title><secondary-title>Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen<\/secondary-title><\/titles><dates><year>2012<\/year><\/dates><electronic-resource-num>10.1159\/000336871<\/electronic-resource-num><urls><related-urls><url>https:\/\/core.ac.uk\/download\/16432283.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chiara Russo<\/author><author>Franziska Ferk<\/author><author>Miroslav Mi\u0161\u00edk et al.<\/author><\/authors><\/contributors><titles><title>Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells<\/title><secondary-title>Archives of Toxicology<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1007\/s00204-018-2322-9<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-018-2322-9.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gemma Navarro<\/author><author>Katia Varani<\/author><author>Alejandro Lillo et al.<\/author><\/authors><\/contributors><titles><title>Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1\/CB2 heteromer receptors<\/title><secondary-title>Pharmacological Research<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1016\/j.phrs.2020.104940<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043661820312482<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samuel B\u00fcechi<\/author><\/authors><\/contributors><titles><title>Wirksamkeit von Cannabidiol: Klinische Studien mit Cannabidiol und Cannabidiol-haltigen Extrakten<\/title><secondary-title>Schweizerische Zeitschrift f\u00fcr Ganzheitsmedizin \/ Swiss Journal of Integrative Medicine<\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.1159\/000484886<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1159\/000484886<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mark Feldman<\/author><author>Ronit Vogt Sionov<\/author><author>Raphael Mechoulam et al.<\/author><\/authors><\/contributors><titles><title>Anti-Biofilm Activity of Cannabidiol against Candida albicans<\/title><secondary-title>Microorganisms<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.3390\/microorganisms9020441<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2076-2607\/9\/2\/441\/pdf?version=1613815842<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jian Huang<\/author><author>Xiao Fan<\/author><author>Xueqin Jin et al.<\/author><\/authors><\/contributors><titles><title>Cannabidiol inhibits Nav channels through two distinct binding sites<\/title><secondary-title>Nature Communications<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1038\/s41467-023-39307-6<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41467-023-39307-6.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Chiara Russo<\/author><author>Margherita Lavorgna<\/author><author>Roberta Nugnes et al.<\/author><\/authors><\/contributors><titles><title>Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin<\/title><secondary-title>Scientific Reports<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1038\/s41598-021-01975-z<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41598-021-01975-z.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sasithorn Limsuwan<\/author><author>Natthaporn Phonsatta<\/author><author>Atikorn Panya et al.<\/author><\/authors><\/contributors><titles><title>Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs<\/title><secondary-title>Frontiers in Veterinary Science<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.3389\/fvets.2024.1389810<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2024.1389810\/pdf?isPublishedV2=False<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Amorphous Solid Dispersion Hydrogel Platform for Transdermal Delivery of Cannabidiol with Therapeutic Potential for Dermatitis.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/pharmaceutics18060666<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13306709?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Encapsulation of Cannabidiol in Chitosan-Stabilized Argan Oil Nanoemulsion as a Potential Dermal Drug Delivery System for Psoriasis Treatment.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/pharmaceutics18030286<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13029121?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Design, synthesis, and biological profiling of fluorinated cannabidiol and cannabigerol derivatives as promising therapeutic agents.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1186\/s42238-026-00403-1<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC12964675?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Moreira FA<\/author><author>de Oliveira ACP<\/author><author>Santos VR et al.<\/author><\/authors><\/contributors><titles><title>Cannabidiol and epilepsy.<\/title><secondary-title>International review of neurobiology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1016\/bs.irn.2024.03.009<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jimbo Sotomayor<\/author><author>Ruth Elizabeth<\/author><\/authors><\/contributors><titles><title>Cannabidiol: uso en epilepsias refractarias<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2017<\/year><\/dates><electronic-resource-num>10.33588\/rn.6504.2016573<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Rose Chesworth<\/author><author>David Cheng<\/author><author>Chloe Staub et al.<\/author><\/authors><\/contributors><titles><title>Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer\u2019s disease mouse model<\/title><secondary-title>Frontiers in Pharmacology<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.3389\/fphar.2022.931384<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.3389\/fphar.2022.931384<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Carley Marie Huffstetler<\/author><author>Brigitte Cochran<\/author><author>Camilla Ann May et al.<\/author><\/authors><\/contributors><titles><title>Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner<\/title><secondary-title>Pharmacology Biochemistry and Behavior<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1016\/j.pbb.2022.173498<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0091305722001770\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Eva Tav\u010dar Benkovi\u0107<\/author><author>Marko Vidak<\/author><\/authors><\/contributors><titles><title>Experimental investigation and thermodynamic modelling of cannabidiol and curcumin in different solvents<\/title><secondary-title>Journal of Molecular Liquids<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1016\/j.molliq.2024.125511<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1016\/j.molliq.2024.125511<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015\/2283.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.2903\/j.efsa.2026.10154<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13586991?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>In Silico<\/i> Exploration of Cannabidiol Interactions with Outer Membrane Proteins in Salmonella<\/i> Typhimurium LT2.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/ijms27188247<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13607420?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Safety of cannabidiol isolated from Cannabis sativa<\/i> L. as a novel food pursuant to Regulation (EU) 2015\/2283.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.2903\/j.efsa.2026.10318<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13591334?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Design, Synthesis, In Silico and In Vitro Pharmacological Profiling of Cannabidiol-like Synthetic Analogues as Multi-Target Anti-Alzheimer's Agents.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.3390\/molecules31152657<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13468590?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"